Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.

L Penso Rosemary Dray-Spira Alain Weill Mahmoud Zureik Emilie Sbidian

Published in: The British journal of dermatology (2021)

Systemic treatments for psoriasis (including biologics) were not associated with increased risk of in-hospital mortality due to COVID-19. These results support maintaining systemic treatment for psoriasis during the pandemic.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
combination therapy
drug induced